Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model

QR Code

Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model

Enterovirus 71 (EV71) is a type of human virus belonging to the Enterovirus genus within the Picornaviridae family. The virus mainly causes hand, foot and mouth disease in children which sometimes lead to severe neurological complications. Outbreaks of EV71 infections are serious health threats sinc...

Full description

Bibliographic Details
Main Author:	Ch'ng, Wei Choong
Format:	Thesis
Language:	English English
Published:	2010
Subjects:	Enteroviruses Proteins Picornaviruses
Online Access:	http://psasir.upm.edu.my/id/eprint/19436/ http://psasir.upm.edu.my/id/eprint/19436/1/FBSB_2010_21_F.pdf

Similar Items

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)

Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)

Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine
by: Othman, Nurulhasanah
Published: (2006)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)

Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice.
by: Ch'ng, Wei Choong, et al.
Published: (2011)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Construction Of Recombinant BCG Expressing The VP1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine [QR186.87. N974 2007 f rb]
by: Othman, Nurulhasanah
Published: (2006)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)

The Nucleocapsid Protein Of Newcastle Disease Virus As A Carrier For The Vp1 Polypeptides Of Enterovirus 71
by: Sivasamugham, Lalita Ambigal
Published: (2005)

Potential usefulness of viral capsid surface proteins (VP1,VP2, VP3 & VP4) for vaccination against common cold
by: Alshrari, Ahmed Subeh D
Published: (2016)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes
by: Cardosa, Mary Jane, et al.
Published: (2003)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)

Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: A report of further observations
by: Longding, Liu, et al.
Published: (2015)

Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease
by: Ong, Kien Chai, et al.
Published: (2010)

Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

A comparison of the VP1, VP2, and VP4 regions for molecular typing of human enteroviruses
by: Perera, D., et al.
Published: (2010)

Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)

High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1
by: Tan, Cheng Siang, et al.
Published: (2007)

Truncated chicken anemia virus-VP3 as a potential anti tumour vaccine
by: Lim, Shen Ni
Published: (2012)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)

Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)

Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013)

Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)

Rational design of live attenuated vaccine by site-directed mutagenesis and deletion in the 5’- non coding region of the enterovirus 71(EV-A71) genome
by: Yee, Isabel Pin Tsin *
Published: (2015)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
by: David, Perera, et al.
Published: (2004)

Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)

A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)

The Aetiology of Hand, Foot and Mouth Disease in Western Australia and the Northern Territory, 2007-2010
by: Williams, David, et al.
Published: (2011)

Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)

The expression of recombinant bacille calmette-guerin (rBCG) containing VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)

Characterization of the adaptive immune responses in enterovirus a71 infection / Aw Yong Kam Leng
by: Aw, Yong Kam Leng
Published: (2016)